source
- Abridge secures strategic investment from Eli Lilly and partners with Nvidia on AI foundation modelAbridge, a health‑tech AI company, announced two new deals on Thursday in New York. Eli Lilly will make a strategic investment in Abridge, signaling pharma interest in AI scribes that document vis…
- Camurus receives second complete response letter for acromegaly drug CAM2029; Teva announces workforce reductionsCamurus reported that the FDA issued a second complete response letter for its investigational acromegaly therapy CAM2029, citing issues related to a third‑party manufacturer. The agency’s concern…